BIO Testifies on Drug Safety Provisions of Draft FDA Globalization Act
May 01, 2008
May 01, 2008
WASHINGTON, May 1 -- The Biotechnology Industries Association issued the following news release:
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on his testimony today before the House Energy and Commerce Subcommittee on Health regarding the drug safety provisions of the discussion draft of the Food and Drug Administration Globalization Act:
"BIO and our members will continue to work closely with the Fo . . .
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on his testimony today before the House Energy and Commerce Subcommittee on Health regarding the drug safety provisions of the discussion draft of the Food and Drug Administration Globalization Act:
"BIO and our members will continue to work closely with the Fo . . .